We specifically selected four different human glioma cell lines, U87, U251, LN18 and SF767 to have a panel of cells with different mutations (p53, PTEN, and MGMT), and sensitivity to temozolomide treatment generally found in glioblastoma (S1A Fig). The gene discussed is TP53; the disease is central nervous system cancer.